Translational Oncology - Clinical Trial Services

 

Pre-screening of patients for clinical studies
Development and monitoring, in clinical studies, of surrogate efficiency assays
Development and commercialization of pharmacodagnostic assays
Treatment failure analysis
Tumor marker surveys
Drug synergy studies

TMD’s unique portfolio of competencies makes it an ideal partner for bio-pharmaceutical companies in the challenging journey from pre-clinical research through all phases of clinical development. TMD is a GLP and a GCP compliant laboratory.

TMD covers the full spectrum of services needed for clinical trial testing of oncology pharmaceutical products - ranging from specific instructions for proper specimen preparation and handling, to special handling, transport and storage of fixed tissue specimens. TMD also provides leading edge specimen testing services and biological characterization of tumors. Refer to the
Technologies section for a comprehensive description of available services.
 

TMD employs the following Clinical Trials Management Process:
 

Receive specimens directly from Client or from the investigational sites

Logistics to handle specimen shipment globally

Communication with investigational site to ensure proper collection and shipment of specimens to TMD

Provision of tissue collection kits containing phosphatase inhibitors to preserve the antigenicity of phosphroylated proteins

Storage of patient material

Testing of patient material

Tracking of testing information

All biomarker assays are fully validated

Summary of results upon completion of the study

Post-study consultation and follow-up as needed

 
 

Pre-Clinical Services

Clinical Trial Services